Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis
- 1 January 2003
- journal article
- Published by Elsevier in Tuberculosis
- Vol. 83 (6) , 373-378
- https://doi.org/10.1016/j.tube.2003.07.001
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Risk of tuberculosis among healthcare workers: can tuberculosis be considered as an occupational disease?Respiratory Medicine, 2002
- Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxideProceedings of the National Academy of Sciences, 2002
- Investigation of polymeric nanoparticles as carriers of enalaprilat for oral administrationInternational Journal of Pharmaceutics, 2002
- In Vitro and In Vivo Evaluation of Oral Heparin–Loaded Polymeric Nanoparticles in RabbitsCirculation, 2002
- Production and Characterization of a Budesonide Nanosuspension for Pulmonary AdministrationPharmaceutical Research, 2002
- Prolonged Anti-Inflammatory Action of DL-Lactide/Glycolide Copolymer Nanospheres Containing Betamethasone Sodium Phosphate for an Intra-Articular Delivery System in Antigen-Induced Arthritic RabbitPharmaceutical Research, 2002
- Treatment of Tuberculosis Using a Combination of Sustained-Release Rifampin-Loaded Microspheres and Oral Dosing with IsoniazidAntimicrobial Agents and Chemotherapy, 2001
- Therapeutic Efficacy of Poly( dl -Lactide-Co-Glycolide)-Encapsulated Antitubercular Drugs against Mycobacterium tuberculosis Infection Induced in MiceAntimicrobial Agents and Chemotherapy, 2001
- Biodegradation and biocompatibility of PLA and PLGA microspheresPublished by Elsevier ,1999
- Lung specific stealth liposomes: stability, biodistribution and toxicity of liposomal antitubercular drugs in miceBiochimica et Biophysica Acta (BBA) - General Subjects, 1997